Home / Modafinil regulatory updates, 2026
Modafinil regulatory updates, 2026
This page is a reference summary of published evidence and regulatory documents. It is not a substitute for individual medical advice, and it is not a recommendation to take or avoid any medicine.
Medically reviewed by Dr. Sofia Lindqvist, · Last reviewed 11 August 2026
Modafinil sits in different legal categories depending on where you are standing. It is prescription-only almost everywhere, controlled in some jurisdictions, and treated differently again for personal import.
This page tracks movement in 2026. Confirmed changes are stated plainly. Items still under consultation are marked.
This page tracks movement in 2026. Confirmed changes are stated plainly. Items still under consultation are marked.
On this page
Three layers that are often confused
Prescription status, controlled-substance scheduling and personal import allowance are separate questions. A country can require a prescription without scheduling the drug, and can schedule it while still permitting a small personal import with documentation.
| Layer | Question it answers |
|---|---|
| Prescription status | Can it be dispensed without a prescriber? |
| Scheduling | Is it a controlled substance, and at what level? |
| Personal import | May an individual bring in or receive a supply? |
Under review in 2026
Several agencies have open consultations touching wakefulness agents, mostly on prescribing indications and on pregnancy warnings rather than on scheduling. Consultations do not change the law until they close and an instrument is made.
Anything listed as under review here should be confirmed against the agency register before you rely on it. Verify with the agency
Anything listed as under review here should be confirmed against the agency register before you rely on it. Verify with the agency
What a change actually changes
Rescheduling changes how a drug is stored, prescribed and repeated. An indication narrowing changes what a prescriber can write it for on-label. A warning addition changes the label but not availability.
Most 2026 activity on wakefulness agents concerns labelling and prescribing guidance, not availability.
Frequently asked questions
Is modafinil legal to import for personal use?
It depends on the jurisdiction, and the rule is separate from prescription status. The country table on the regulatory tracker sets out each case.
How often is this page updated?
Whenever a tracked jurisdiction publishes a change, and reviewed on a rolling basis regardless.